Scottsdale, AZ11 Active Studies

Multiple Sclerosis Clinical Trials in Scottsdale, AZ

Find 11 actively recruiting multiple sclerosis clinical trials in Scottsdale, AZ. Connect with local research sites and explore new treatment options.

11
Active Trials
10
Sponsors
57,349
Enrolling

Recruiting Multiple Sclerosis Studies in Scottsdale

About Multiple Sclerosis Clinical Trials in Scottsdale

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 11 multiple sclerosis clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 57,349 participants. Research is being sponsored by Proton Collaborative Group, TG Therapeutics, Inc., Zenas BioPharma (USA), LLC and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Scottsdale — FAQ

Are there multiple sclerosis clinical trials in Scottsdale?

Yes, there are 11 multiple sclerosis clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 11 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 19, 2026 from ClinicalTrials.gov